AID beneficial and safe option for improving HbA1C among insulin-dependent type 2 diabetes patients: JAMA Dr Riya Dave20 Feb 2025 8:30 AM ISTA nonrandomized clinical trial found that HbA1c levels decreased in a diverse group of adults with type 2 diabetes after starting automated insulin...
Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management Farhat Nasim17 Feb 2025 7:56 PM ISTNew Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin...
Oral Glucose-Lowering Agents Fall Short to Insulin for containing gestational diabetes Outcomes: JAMA Dr Riya Dave1 Feb 2025 8:15 AM ISTResearchers have determined that in comparison to insulin treatment, the use of a strategy of oral glucose-lowering agents with metformin and...
Advanced Hybrid Closed-Loop Therapy Improves Glycemic Control During Pregnancy and Postpartum in Type 1 Diabetes: Study Medha Baranwal4 Dec 2024 9:00 AM ISTBelgium: A new analysis from the CRISTAL randomized controlled trial highlights the benefits of advanced hybrid closed-loop (AHCL) therapy in women...
Tirzepatide bests Prandial Insulin as add-on option to basal Insulin for improving glycemic control among diabetics Dr. Kamal Kant Kohli5 Nov 2023 8:00 PM ISTA recent study reveals tirzepatide as a highly effective and safer alternative to prandial insulin for individuals with type 2 diabetes inadequately...
Add on SGLT2 inhibitors to insulin therapy in diabetes patients lowers blood sugar, BP, and weight without reducing eGFR Aditi2 Aug 2023 11:30 AM ISTSGLT2 inhibitors are a class of drugs that lower blood sugar levels by preventing kidneys from reabsorbing sugar that is created by body and the extra...
De-intensification of bolus insulin in type 2 diabetes after GLP-1 RA initiation improves blood sugar and aids weight loss Medha Baranwal6 Oct 2022 11:15 AM ISTItaly: Using GLP-1 receptor agonists instead of prandial insulin is a valuable strategy to simplify the basal-bolus (BB) insulin regimen while...
Add on Empagliflozin to automated insulin delivery improves glycemic control in type 1 diabetes Dr. Hiral patel19 July 2022 11:00 AM ISTUSA: A new study showed that the use of empagliflozin as an adjunct to automated insulin delivery (AID) improved glycemic management in adults with...
Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: Endocrine Society's Guideline Dr. Kamal Kant Kohli15 Jun 2022 9:15 AM ISTATLANTA: According to a Clinical Practice Guideline issued by the Endocrine Society at ENDO 2022, hospitalized patients with diabetes or hyperglycemia...
Insulin Glargine Induces Less Insulin Antibody Than Other Insulin Regimens MD Bureau11 March 2022 10:00 AM ISTInsulin antibodies (IAs), which were found commonly developed in patients treated with exogenous insulin, might affect glycemic control due to their...
